Ever Supreme Bio Technology Co., Ltd (TPEX:6712)
Taiwan · Delayed Price · Currency is TWD 142.00
+1.50 (1.07%)
Mar 24, 2026, 1:30 PM CST
TPEX:6712 Market Cap
TPEX:6712 has a market cap or net worth of 12.31 billion as of March 23, 2026. Its market cap has decreased by -19.09% in one year.
Market Cap
12.31B
Enterprise Value
11.91B
Revenue
1.02B
Ranking
n/a
PE Ratio
28.79
Stock Price
142.00
Market Cap Chart
Since October 26, 2018, TPEX:6712's market cap has increased from 5.10B to 12.31B, an increase of 141.51%. That is a compound annual growth rate of 12.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 23, 2026 | 12.31B | -14.33% |
| Dec 31, 2025 | 14.37B | 1.47% |
| Dec 31, 2024 | 14.16B | -1.25% |
| Dec 29, 2023 | 14.34B | -4.57% |
| Dec 30, 2022 | 15.02B | 15.46% |
| Dec 30, 2021 | 13.01B | 32.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Polaris Group | 17.11B |
| EirGenix | 17.10B |
| Medigen Vaccine Biologics | 16.31B |
| AP Biosciences | 15.79B |
| TaiMed Biologics | 13.26B |
| Tanvex BioPharma | 11.28B |
| TCM Biotech International | 11.01B |
| Gongwin Biopharm Holdings | 8.80B |